Pathogenic Role of Immune Cells in Rheumatoid Arthritis: Implications in Clinical Treatment and Biomarker Development
2018 · Cells · 463 citations
https://doi.org/10.3390/cells7100161
S
Sin‐Yeang Teow
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
82
Papers
3.6K
Citations
27
h-index
47
i10-index
Sin‐Yeang Teow is an academic researcher from China International Science and Technology Cooperation. The author has contributed to research in topics: Nanoparticle-Based Drug Delivery & Nanoparticles: synthesis and applications & Graphene and Nanomaterials Applications. The author has an h-index of 27, co-authored 70 publications.
ORCID: 0000-0002-3824-0224Papers by this author
worksFabrication of cellulose nanocrystals as potential anticancer drug delivery systems for colorectal cancer treatment
2022 · International Journal of Biological Macromolecules · 71 citations
https://doi.org/10.1016/j.ijbiomac.2021.12.189
5-Fluorouracil Encapsulated Chitosan-Cellulose Fiber Bionanocomposites: Synthesis, Characterization and In Vitro Analysis towards Colorectal Cancer Cells
2021 · Nanomaterials · 61 citations
https://doi.org/10.3390/nano11071691
CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma
2017 · Scientific Reports · 22 citations
https://doi.org/10.1038/s41598-017-12045-8
Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance
2023 · Pharmaceuticals · 12 citations
https://doi.org/10.3390/ph16010110
Role of sirtuin 1 (SIRT1) in regulation of autophagy and nuclear factor-kappa Beta (NF-ĸβ) pathways in sorafenib-resistant hepatocellular carcinoma (HCC)
2024 · Cell Biochemistry and Biophysics · 12 citations
https://doi.org/10.1007/s12013-024-01247-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat